FMC Q3 Results: Adj EPS Guidance $0.05-$0.13 vs $0.63 Est
FMC Corp's Q3 guidance reveals a significant downturn, with adjusted EPS projected at $0.05-$0.13 versus a $0.63 estimate. Sales of $840M-$900M also miss the $950.329M forecast, highlighting broader operational pressures.
*this image is generated using AI for illustrative purposes only.
FMC Corp (NYSE: FMC) issued third-quarter guidance that falls sharply short of market expectations, signaling potential headwinds in its agricultural and specialty chemical operations. The company projects adjusted earnings per share between $0.05 and $0.13, a significant miss against the $0.63 analyst estimate. This wide variance suggests underlying operational challenges or margin compression that investors had not fully priced into their models.
Revenue guidance also trails consensus estimates, with FMC forecasting sales between $840 million and $900 million for the quarter. This range sits well below the $950.329 million expected by analysts. The simultaneous miss on both top-line revenue and bottom-line profitability indicates a broad-based softness in demand or pricing power across its key segments during the period.
Guidance vs. Estimates
The divergence between FMC’s internal outlook and external analyst projections is substantial across both key financial metrics.
| Metric | FMC Guidance | Analyst Estimate |
|---|---|---|
| Adjusted EPS | $0.05 – $0.13 | $0.63 |
| Sales | $840 million – $900 million | $950.329 million |
What the Numbers Show
The most striking aspect of this guidance is the magnitude of the EPS miss. With the upper end of the guided range ($0.13) representing less than 21% of the estimated $0.63, the company is signaling a severe deterioration in profitability relative to expectations. This is not a minor variance but a structural shift in the quarterly outlook. When combined with revenue falling short by at least $50 million at the high end of the guidance range, it suggests that volume declines or price erosion are impacting the business more deeply than previously anticipated. Investors should monitor upcoming disclosures for details on segment-specific performance and cost-saving measures.
What specific operational headwinds or margin compression factors in the agricultural and specialty chemical segments are driving this severe EPS miss?
How will FMC adjust its cost-saving measures or strategic initiatives to address the broader-than-expected softness in demand and pricing power?
Are analysts likely to downgrade their full-year earnings and revenue forecasts for FMC given the magnitude of this third-quarter guidance gap?
18
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
